Jomed To Begin Anastomosis Device Clinicals In Second Quarter 2000
This article was originally published in The Gray Sheet
Swedish-based stent manufacturer Jomed is looking to start European clinical studies for a sutureless graft connector anastomosis system by the second quarter of 2000, the company said, in the wake of promising six-month animal data.
You may also be interested in...
Guidant's planned acquisition of minimally invasive cardiac surgery device maker CardioThoracic Systems for $313 mil. in stock provides greater access to cardiac surgeons as well as a platform for growth in the cardiac surgery market.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.